CureCell
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $195M
Overview
A UAE-based cell therapy company developing innovative treatments for cancer and immune disorders.
OncologyImmunology
Technology Platform
A cell engineering platform focused on developing next-generation CAR constructs and allogeneic cell therapies for oncology and autoimmunity.
Funding History
1Total raised:$195M
Series E$195M
Opportunities
Positioning as a regional cell therapy pioneer can facilitate access to unique patient cohorts and strategic government funding.
Risk Factors
High costs, complex manufacturing, and fierce competition in cell therapy pose significant commercial and technical risks.
Competitive Landscape
Enters a crowded global field of cell therapy developers, competing with giants like Novartis and Gilead as well as numerous innovative biotechs.